[144] Alexander & Baldwin, Inc. SEC Filing

Rhea-AI Filing Summary

Notice of proposed sale under Rule 144 for Common stock. The filing shows an intended sale of 700 shares through UBS Financial Services, Inc. with an aggregate market value of $11,900.00. The filer reports acquiring the shares on 02/01/2023 as compensation from the issuer and indicates prior sales of 700 shares each on 07/10/2025, 08/11/2025, and 09/10/2025 with gross proceeds of $12,552.05, $12,700.80, and $13,128.78, respectively. The filing lists 72,753,270 shares outstanding and an approximate sale date of 10/10/2025. The signer affirms no undisclosed material adverse information and provides standard Rule 144 declarations.

Insights

Securities Compliance Analyst

Routine Rule 144 notice documenting planned sale and prior recent disposals.

The notice records a proposed sale of 700 common shares via UBS Financial Services with acquisition dated 02/01/2023 labeled as compensation, and three prior single-month sales in 07/2025, 08/2025, and 09/2025.

Compliance hinges on the filer’s representation of no undisclosed material adverse information and adherence to procedural timing under Rule 144; investors should note the filing confirms planned disposal under the Rule’s safe-harbor framework within the stated dates.

Equity Markets Analyst

Small-volume insider/affiliate sales recorded; limited market impact indicated.

The filing shows the proposed sale amount (700 shares, aggregate market value $11,900.00) and discloses 72,753,270 shares outstanding, providing context for scale relative to the issuer’s float.

Given the repeated monthly disposals of 700 shares across three months and the upcoming 10/10/2025 sale, the transactions appear orderly and broker-handled; watch reported sale completion notices or larger follow-on filings for any change in trend over the next month.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services, Inc. 11 Madison Ave 4th Floor New York NY 10010	700	11900.00	72753270	10/10/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/01/2023	Compensation	Issuer			700	02/01/2023	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
The Meredith J Ching Revocable Living Trust 22 BISHOP STREET, P.O. BOX 3440 HONOLULU HI 96801	Common	07/10/2025	700	12552.05
The Meredith J Ching Revocable Living Trust 822 BISHOP STREET, P.O. BOX 3440 HONOLULU HI 96801	Common	08/11/2025	700	12700.80
The Meredith J Ching Revocable Living Trust 822 BISHOP STREET, P.O. BOX 3440 HONOLULU HI 96801	Common	09/10/2025	700	13128.78

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the ALEX Form 144 disclose?

The filing notifies a proposed sale of 700 common shares via UBS Financial Services with aggregate market value $11,900.00 and an approximate sale date of 10/10/2025.

When were the shares acquired for this ALEX filing?

The filing shows the filer acquired the 700 shares on 02/01/2023 as compensation from the issuer.

Has the filer sold shares recently for ALEX?

Yes; the filing discloses sales of 700 shares each on 07/10/2025, 08/11/2025, and 09/10/2025 with gross proceeds of $12,552.05, $12,700.80, and $13,128.78 respectively.

How large is the company’s share count in this filing?

The document lists 72,753,270 shares outstanding.

Does the filer certify there is no undisclosed material information?

Yes; the signer represents they do not know of any material adverse information about the issuer that has not been publicly disclosed.